|Author (Person)||Wood, Matt|
|Author (Corporate)||Health Governance after Brexit|
|Publisher||UK in a Changing Europe|
|Series Title||UKiCE Reports|
|Publication Date||July 2020|
|Content Type||Research Paper|
This research briefing indicates the need for greater transparency to show the implications of the current UK-EU and UK-US trade negotiations for the NHS, and health more generally.
While both negotiations are principally about trade, they have profound implications for health, covering a range of issues from medical product certification and distribution, quality of regulation, and the broader relationship between public and private healthcare providers. This research compares the negotiating positions of parties in both sets of trade negotiations, and evaluates the implications of those positions for health and the NHS. The authors analyses United Kingdom (UK) and European Union (EU) documentation including draft negotiating documents from both sides, and papers detailing the UK’s negotiating position in UK-US trade negotiations, as well as a range of documentary and academic evidence setting out the likely position the United States (US) will take in those negotiations.
|Subject Categories||Health, Trade|
|Subject Tags||Brexit, External Trade | Trade Agreements, Public Health|
|Countries / Regions||United Kingdom, United States|
|International Organisations||European Union [EU]|